Skip to main content
. Author manuscript; available in PMC: 2014 Jul 9.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Jun 19;50(1):101–106. doi: 10.1167/iovs.08-2165

TABLE 1.

Baseline characteristics of 29,532 men and 12,176 women by incident AMD status

Unadjusted Age-and Sex-Adjusted
Incident AMD Present Absent Present Absent
Sample (N) 152 41,556 152 41,556
Female (%) 27.63 29.20
Age (y) 54.22 ± 0.92 43.09 ± 0.05*
Follow-up duration (y) 8.02 ± 0.14 7.66 ± 0.01 8.31 ± 0.16 7.68 ± 0.01*
Education (y) 16.23 ± 0.20 16.34 ± 0.01 16.48 ± 0.20 16.57 ± 0.01
Running distance (km/day) 4.34 ± 0.23 5.33 ± 0.02* 4.60 ± 0.26 5.28 ± 0.02
Years of running 13.77 ± 0.61 12.25 ± 0.04 11.50 ± 0.59 12.32 ± 0.04
10-km performance (m/s) 3.51 ± 0.05 3.82 ± 0.00* 3.76 ± 0.04 3.82 ± 0.00
BMI (kg/m2) 23.23 ± 0.24 23.11 ± 0.01 23.38 ± 0.20 23.34 ± 0.01
Waist circumference (cm) 82.19 ± 0.83 79.95 ± 0.05 81.16 ± 0.51 80.16 ± 0.04
Ever smoked (%) 53.95 36.38* 45.23 39.12
Meat (servings/wk) 2.94 ± 0.21 2.52 ± 0.01 3.17 ± 0.20 2.55 ± 0.02
Fish (servings/wk) 1.67 ± 0.12 1.46 ± 0.01 1.48 ± 0.11 1.47 ± 0.01
Fruit (pieces/wk) 10.69 ± 0.68 11.17 ± 0.04 9.41 ± 0.70 10.92 ± 0.05
Alcohol (g/day) 11.07 ± 1.39 8.89 ± 0.06 1.02 ± 0.10 0.91 ± 0.01
Hypertensive medications (%) 9.21 3.34* 4.49 2.55
Lipid-lowering medication (%) 3.95 1.92 1.65 1.61

Data are the mean ± SE. Significance of difference by analysis of covariance:

*

P ≤ 0.0001;

P ≤ 0.05;

P ≤ 0.01.